ARVO Meeting Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sundaram, V.
Right arrow Articles by Michaelides, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sundaram, V.
Right arrow Articles by Michaelides, M.
Invest Ophthalmol Vis Sci 2012;53: E-Abstract 2678.
© 2012 ARVO


2678—D1120

Cone Photoreceptor Structure in Achromatopsia

Venki Sundaram1A, Caroline Wilde1A, Andrew R. Webster1B, Anthony T. Moore1A, Marko Nardini1A, Robin R. Ali2A, James W. Bainbridge2, Joseph Carroll3 and Michel Michaelides4

AOphthalmology, BMolecular Genetics, 1Institute of Ophthalmology, London, United Kingdom
ADiv of Molecular Therapy,2UCL Institute of Ophthalmology, London, United Kingdom
3Ophthalmology, Medical College of Wisconsin, Milwaukee, Wisconsin
4Medical Retina Department, Moorfields Eye Hospital, London, United Kingdom

Commercial Relationships: Venki Sundaram, None; Caroline Wilde, None; Andrew R. Webster, None; Anthony T. Moore, None; Marko Nardini, None; Robin R. Ali, None; James W. Bainbridge, None; Joseph Carroll, None; Michel Michaelides, None

Support: Foundation Fighting Blindness (FFB; Owings Mills, MD, USA), Moorfields Special Trustees, Fight for Sight, NIHR to BRC at Moorfields, UCL Institute of Ophthalmology

Abstract

Purpose:Achromatopsia (ACHM) is considered to be a stationary cone disorder with animal studies suggesting it may be a good candidate for gene replacement therapy. Recent clinical studies have suggested that progressive cone loss may occur with age. This study further investigates the integrity of cone photoreceptors in ACHM.

Methods:60 eyes of 30 patients with ACHM underwent spectral domain optical coherence tomography (SDOCT) imaging (49 B-scans, 20°x20°, 12 frames per B-scan). SDOCT retinal appearance was classified as (1) normal outer retinal structure, (2) inner segment/outer segment disruption, (3) hyporeflective zone presence and (4) complete cone and RPE cell layer disruption.

Results:Mean age of subjects was 26.3 years (range 8-53 years). 20% of eyes had normal outer retinal structure, 30% had inner segment/outer segment disruption, 37 % had a hyporeflective zone present, and 13 % had complete cone and RPE cell layer disruption. There was high inter-eye correlation of SDOCT changes. There was no significant difference in age of subjects (p=0.760) or visual acuity (p=0.152) between the SDOCT change categories.

Conclusions:SDOCT changes in ACHM can vary from apparently normal outer retinal structure to complete cone loss with RPE involvement. These changes were not present in an age-dependent manner, or associated with visual acuity; implying that the window of opportunity for gene therapy intervention may extend into adulthood, and prospective patients need to be assessed on an individual basis, irrespective of age.

Keywords: gene transfer/gene therapy • photoreceptors • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound)

© 2012, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH